Vertex Pharmaceuticals Incorporated
31 active trials across 9 therapeutic areas
31
Active Trials
10
Phase 1
9
Phase 2
17
Phase 3
9
Therapeutic Areas
Respiratory
10 active / 78 total
Immunology
9 active / 13 total
Cardiovascular
7 active / 9 total
Pain
5 active / 39 total
Rare Disease
4 active / 5 total
Oncology
3 active / 4 total
Metabolic
3 active / 3 total
CNS
0 active / 2 total
Musculoskeletal
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)